Jimmy Volmink

Jimmy Volmink

Auto-generated profile, based on publicly available information

Jimmy Volmink

Stellenbosch University

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2008 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
SASalla Atkins
Salla Atkins
SLSimon Lewin
Simon Lewin
HSHelen Smith
Helen Smith
MEMark Emmanuel Engel
Mark Emmanuel Engel
AFAtle Fretheim
Atle Fretheim
JVJimmy Volmink
Jimmy Volmink
Qualitative synthesis has become more commonplace in recent years. Meta-ethnography is one of several methods for synthesising qualitative research and is being used increasingly within health care research. However, many aspects of the steps in the process remain ill-defined. We utilized the seven stages of the synthesis process to synthesise qualitative research on adherence to tuberculosis treatment. In this paper we discuss the methodological and practical challenges faced; of particular note are the methods used in our synthesis, the additional steps that we found useful in clarifying the process, and the key methodological challenges encountered in implementing the meta-ethnographic approach. The challenges included shaping an appropriate question for the synthesis; identifying relevant studies; assessing the quality of the studies; and synthesising findings across a very large number of primary studies from different contexts and research traditions. We offer suggestions that may assist in undertaking meta-ethnographies in the future. Meta-ethnography is a useful method for synthesising qualitative research and for developing models that interpret findings across multiple studies. Despite its growing use in health research, further research is needed to address the wide range of methodological and epistemological questions raised by the approach.

11 June 2007 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SMSalla Munro
Salla Munro
SLSimon Lewin
Simon Lewin
TSTanya Swart
Tanya Swart
JVJimmy Volmink
Jimmy Volmink
Suboptimal treatment adherence remains a barrier to the control of many infectious diseases, including tuberculosis and HIV/AIDS, which contribute significantly to the global disease burden. However, few of the many interventions developed to address this issue explicitly draw on theories of health behaviour. Such theories could contribute to the design of more effective interventions to promote treatment adherence and to improving assessments of the transferability of these interventions across different health issues and settings.

5 December 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
DGDavid Guwatudde
David Guwatudde
JMJoan Mutyoba
Joan Mutyoba
RKRobert Kalyesubula
Robert Kalyesubula
CLCarien Laurence
Carien Laurence
CAClement Adebamowo
Clement Adebamowo
SDShona Dalal
Shona Dalal
Hypertension, the leading single cause of morbidity and mortality worldwide, is a growing public health problem in sub-Saharan Africa (SSA). Few studies have estimated and compared the burden of hypertension across different SSA populations. We conducted a cross-sectional analysis of blood pressure data collected through a cohort study in four SSA countries, to estimate the prevalence of pre-hypertension, the prevalence of hypertension, and to identify the factors associated with hypertension. Participants were from five different population groups defined by occupation and degree of urbanization, including rural and peri-urban residents in Uganda, school teachers in South Africa and Tanzania, and nurses in Nigeria. We used a standardized questionnaire to collect data on demographic and behavioral characteristics, injuries, and history of diagnoses of chronic diseases and mental health. We also made physical measurements (weight, height and blood pressure), as well as biochemical measurements; which followed standardized protocols across the country sites. Modified Poison regression modelling was used to estimate prevalence ratios (PR) as measures of association between potential risk factors and hypertension. The overall age-standardized prevalence of hypertension among the 1216 participants was 25.9 %. Prevalence was highest among nurses with an age-standardized prevalence (ASP) of 25.8 %, followed by school teachers (ASP = 23.2 %), peri-urban residents (ASP = 20.5 %) and lowest among rural residents (ASP = 8.7 %). Only 50.0 % of participants with hypertension were aware of their raised blood pressure. The overall age-standardized prevalence of pre-hypertension was 21.0 %. Factors found to be associated with hypertension were: population group, older age, higher body mass index, higher fasting plasma glucose level, lower level of education, and tobacco use. The prevalence of hypertension and pre-hypertension are high, and differ by population group defined by occupation and degree of urbanization. Only half of the populations with hypertension are aware of their hypertension, indicating a high burden of undiagnosed and un-controlled high blood pressure in these populations.

17 October 2007
Verified
Reference Entry
Open access
JVJimmy Volmink
Jimmy Volmink
PGPaul Garner
Paul Garner
Using a pilot system we have categorised this review as: Current question ‐ no update intended (Results conclusive) Please see "Published notes" section of the review for more details. For tuberculosis treatment, policies have been introduced to encourage adherence to treatment regimens. One such policy is directly observed therapy (DOT), which involves people directly observing patients taking their antituberculous drugs. To compare DOT with self administration of treatment or different DOT options for people requiring treatment for clinically active tuberculosis or prevention of active disease. In May 2007, we searched the Cochrane Infectious Diseases Group Specialized Register, CENTRAL (The Cochrane Library 2007, Issue 2), MEDLINE, EMBASE, LILACS, and mRCT. We also checked article reference lists and contacted relevant researchers and organizations. Randomized and quasi‐randomized controlled trials comparing a health worker, family member, or community volunteer routinely observing people taking antituberculous drugs compared with routine self administration of treatment at home. We include people requiring treatment for clinically active tuberculosis or medication for preventing active disease. Both authors independently assessed trial methodological quality and extracted data. Data were analysed using relative risks (RR) with 95% confidence intervals (CI) and the fixed‐effect model when there was no statistically significant heterogeneity (chi square P > 0.1). Trials of drug users were analysed separately. Eleven trials with 5609 participants met the inclusion criteria. No statistically significant difference was detected between DOT and self administration in terms of cure (RR 1.02, 95% CI 0.86 to 1.21, random‐effects model; 1603 participants, 4 trials), with similar results for cure plus completion of treatment. When stratified by location, DOT provided at home compared with DOT provided at clinic suggests a possible small advantage with home‐based DOT for cure (RR 1.10, 95% CI 1.02 to 1.18; 1365 participants, 3 trials). There was no significant difference detected in clinical outcomes between DOT at a clinic versus by a family member or community health worker (2 trials), or for DOT provided by a family member versus a community health worker (1326 participants, 1 trial). Two small trials of tuberculosis prophylaxis in intravenous drugs users found no statistically significant difference between DOT and self administration (199 participants, 1 trial) or a choice of location for DOT for completion of treatment (108 participants, 1 trial). The results of randomized controlled trials conducted in low‐, middle‐, and high‐income countries provide no assurance that DOT compared with self administration of treatment has any quantitatively important effect on cure or treatment completion in people receiving treatment for tuberculosis.

21 January 2009
Verified
Reference Entry
Closed access
PDF file
LGLiesl Grobler
Liesl Grobler
Ben J. MaraisBen J. Marais
Ben J. Marais
SMSa Mabunda
Sa Mabunda
PMPn Marindi
Pn Marindi
HRHelmuth Reuter
Helmuth Reuter
JVJimmy Volmink
Jimmy Volmink

24 January 2007
Verified
Reference Entry
Closed access
JVJimmy Volmink
Jimmy Volmink
NSNandi Siegfried
Nandi Siegfried
LMLize Van Der Merwe
Lize Van Der Merwe
PBPeter Brocklehurst
Peter Brocklehurst